On-X Life Technologies, Inc.
On-X Life Technologies Completes Enrollment in High-Risk Patient Group of Low-Anticoagulation Trial
Published in Blood Weekly, November 5th, 2009
Austin-based On-X® Life Technologies, Inc. (On-X LTI), manufacturers of the On-X® Prosthetic Heart Valve and On-X® carbon products for orthopedic implants, announced that enrollment in the High-Risk Patient Group of the landmark PROACT (Prospective Randomized On-X Anticoagulation Clinical Trial) is complete. While data is still to be analyzed, it is a positive indication that the trial has reached full enrollment of the High-Risk Aortic Valve Replacement Patient Group without an adverse incident that would lead the study's Data Safety Committee to conclude the study prematurely.
Based upon existing clinical data, The U.S. Food and Drug Administration...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-11-05)
More Articles from Blood Weekly
- Johns Hopkins University Bloomberg School of Public Health
Review: Pneumococcal conjugate vaccines effective at preventing child deaths - Lifespan
Better blood screening process needed to prevent babesiosis transmission - Wiley-Blackwell
Drinking coffee slows progression of liver disease in chronic hepatitis C sufferers - Alcoholism
Studies from D.M. Berkowitz and co-researchers yield new data on alcoholism - American Chemical Society
Teachers and Students Nationwide Receive the Merck Index During National Chemistry Week - Aspergillosis
Researchers from University of London, Imperial College detail new studies and findings in the area of aspergillosis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
